2024-03-08 | Sale | Pacira BioSciences, Inc. PCRX | director | | $30.60 | $2.75M | -16.37% | |
2024-03-07 | Sale | Pacira BioSciences, Inc. PCRX | director | | $30.81 | $870,598 | -14.21% | |
2024-03-06 | Sale | Pacira BioSciences, Inc. PCRX | director | | $29.67 | $31,628 | -12.52% | |
2023-12-19 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $1.37 | $41,100 | +88.32% | |
2023-05-11 | Sale | Pacira BioSciences, Inc. PCRX | director | | $41.78 | $209,527 | -25.58% | |
2022-09-15 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $1.71 | $256,500 | -4.49% | |
2022-03-01 | Sale | Pacira BioSciences, Inc. PCRX | director | | $67.75 | $92,072 | -19.08% | |
2022-02-28 | Sale | Pacira BioSciences, Inc. PCRX | director | | $66.83 | $1.91M | -17.53% | |
2021-09-21 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $6.75 | $202,500 | -58.36% | |
2021-03-23 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $10.23 | $102,300 | -37.74% | |
2021-03-18 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $10.55 | $31,660 | -38.95% | |
2021-03-04 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $9.27 | $13,898 | -29.09% | |
2020-09-16 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $5.70 | $14,527 | +72.12% | |
2020-05-11 | Purchase | Cardiff Oncology, Inc. CRDF | director | | $1.34 | $600,000 | +646.27% | |
2018-11-19 | Purchase | Pacira BioSciences, Inc. PCRX | director | | $46.18 | $415,620 | -12.65% | |
2018-11-07 | Purchase | Pacira BioSciences, Inc. PCRX | director | | $51.29 | $410,320 | -21.28% | |
2015-03-13 | Purchase | Pacira BioSciences, Inc. PCRX | director | | $93.83 | $93,830 | -30.59% | |
2013-09-09 | Sale | ResMed Inc. RMD | director | | $50.05 | $600,612 | -0.55% | |
2012-08-07 | Sale | ResMed Inc. RMD | director | | $36.00 | $1.73M | +23.56% | |
2012-04-17 | Purchase | Pacira BioSciences, Inc. PCRX | director | | $9.75 | $195,000 | +68.69% | |